Therapeutic Na+ channel blockers beneficial for pain syndromes

Drug Development Research

Volumn 54, Issue 3, 2001, Pages 154-158

  Wang, Ging Kuo ^a   Strichartz, Gary R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Local anesthetics; Nerve block; Neuropathic pain

Indexed keywords

LOCAL ANESTHETIC AGENT; SODIUM CHANNEL BLOCKING AGENT;

ARTICLE; CHANNEL GATING; DRUG RESEARCH; HUMAN; NERVE BLOCK; PAIN;

EID: 0036159833     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10014     Document Type: Article

References (4)

1. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stafa LC, Dickenson AH, Wood JH. 1999. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2:541-548.
2. Boas RA, Covino BG, Shahnarian A. 1982. Analgesic response to i.v. lignocaine. Br J Anaesth 54:501-504.
3. Brennan TJ, Umali EF, Zahn PK. 1997. Comparison of pre-versus postincision administration of intrathecal bupivacaine and intrathecal morphine in a rat model of postoperative pain. Anesthesiology 87:1517-1528.
4. Burke D, Henderson DJ, Simpson AM, Faccenda KA, Morrison LM., McGrady EM, McLeod GA, Bannister J. 1999. Comparison of 0.25% S(-)-bupivacaine with 0.25% RS-bupivacaine for epidural analgesia in labour. Br J Anaesth 83:750-755.